Sign in
4

Changes in Ownership

Fulgent Genetics, Inc. Filed Acc 0001209191-23-013286

Chief Executive Officer gave up 2,625 shares (to pay taxes)

  • Chief Executive Officer acquired 55,009 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hsieh Ming · Chief Executive Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-23 Grant or award : show line 1 in the form +7,616 603,787 D
2023-02-23 Grant or award : show line 2 in the form +47,393 651,180 D
2023-02-23 Shares withheld for taxes : show line 3 in the form −2,625 $31.65 $83,081 648,555 D
Loading xslF345X03/doc4.xml…